Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer

  • Manish A. Shah ,

    mas9313@med.cornell.edu

    Affiliation The Weill Cornell Medical College/New York–Presbyterian Hospital, New York, New York, United States of America

  • Zev A. Wainberg,

    Affiliation University of California Los Angeles, Los Angeles, California, United States of America

  • Daniel V. T. Catenacci,

    Affiliation University of Chicago, Chicago, Illinois, United States of America

  • Howard S. Hochster,

    Affiliation Yale University, New Haven, Connecticut, United States of America

  • James Ford,

    Affiliation Stanford University, Stanford, California, United States of America

  • Pamela Kunz,

    Affiliation Stanford University, Stanford, California, United States of America

  • Fa-Chyi Lee,

    Affiliation University of New Mexico, Albuquerque, New Mexico, United States of America

  • Howard Kallender,

    Affiliation GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  • Fabiola Cecchi,

    Affiliation Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  • Daniel C. Rabe,

    Affiliation Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  • Harold Keer,

    Affiliation Exelixis, South San Francisco, California, United States of America

  • Anne-Marie Martin,

    Affiliation GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  • Yuan Liu,

    Affiliation GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  • Robert Gagnon,

    Affiliation GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  • Peter Bonate,

    Affiliation GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  • Li Liu,

    Affiliation GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  • Tona Gilmer,

    Affiliation GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  •  [ ... ],
  • Donald P. Bottaro

    Affiliation Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  • [ view all ]
  • [ view less ]

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.